Patents by Inventor Guido Kroemer

Guido Kroemer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent
    Publication number: 20030166598
    Abstract: The invention concerns the use of Ro5-4864, and compounds derived therefrom, for preparing medicines for treating tumoral pathologies. The invention also concerns said compounds combined with an apoptosis-inducing agent, as combination products for simultaneous, separate or prolonged use, in cancer therapy.
    Type: Application
    Filed: April 8, 2003
    Publication date: September 4, 2003
    Inventors: Didier Decaudin, Guido Kroemer, Marie-France Poupon, Fariba Nemati, Arnaud Beurdeley-Thomas
  • Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator)
    Publication number: 20020068273
    Abstract: The invention is directed to the induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (adenine nucleotide translocator, also called adenine nucleotide translocase or ADP/ATP carrier). Reagents and methods for inducing and/or inhibiting the binding of Vpr to ANT, mitochondrial membrane permeabilization, and apoptosis are provided.
    Type: Application
    Filed: September 12, 2001
    Publication date: June 6, 2002
    Inventors: Etienne Daniel Francois Jacotot, Guido Kroemer, Bernard Pierre Roques, Lena Edelman, Johan Hoebeke, Catherine Brenner-Jan, Anne-Sophie Belzacq
  • Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
    Patent number: 6319931
    Abstract: The present invention relates in particular to a combination product comprising at least one compound with affinity for the mitochondrial benzodiazepine receptor, and to at least one apoptosis-inducing agent for simultaneous or separate use or for use spread out over time, which is intended for the treatment of cancer. Another aspect of the present invention relates to the use of the said compound and/or of the said combination product for the manufacture of a medicinal product intended to facilitate the induction of apoptosis.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: November 20, 2001
    Assignee: Centre National de al Recherche Scientifique (CNRS)
    Inventors: Guido Kroemer, Tamara Hirsch, Didier Decaudin